Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

369 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort.
Vassilakopoulou M, Won M, Curran WJ, Souhami L, Prados MD, Langer CJ, Rimm DL, Hanna JA, Neumeister VM, Melian E, Diaz AZ, Atkins JN, Komarnicky LT, Schultz CJ, Howard SP, Zhang P, Dicker AP, Knisely JPS. Vassilakopoulou M, et al. Among authors: langer cj. Oncology. 2021;99(9):580-588. doi: 10.1159/000516168. Epub 2021 May 6. Oncology. 2021. PMID: 33957633 Free PMC article.
Report of phase II trial of concurrent chemoradiotherapy with radical thoracic irradiation (60 Gy), infusional fluorouracil, bolus cisplatin and etoposide for clinical stage IIIB and bulky IIIA non-small cell lung cancer.
Langer CJ, Curran WJ Jr, Keller SM, Catalano R, Fowler W, Blankstein K, Litwin S, Bagchi P, Nash S, Comis R. Langer CJ, et al. Int J Radiat Oncol Biol Phys. 1993 Jun 15;26(3):469-78. doi: 10.1016/0360-3016(93)90965-x. Int J Radiat Oncol Biol Phys. 1993. PMID: 8390421 Clinical Trial.
Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients.
Coughlin C, Scott C, Langer C, Coia L, Curran W, Rubin P. Coughlin C, et al. Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1351-8. doi: 10.1016/s0360-3016(00)01412-7. Int J Radiat Oncol Biol Phys. 2000. PMID: 11121633 Clinical Trial.
Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience.
Machtay M, Hsu C, Komaki R, Sause WT, Swann RS, Langer CJ, Byhardt RW, Curran WJ. Machtay M, et al. Among authors: langer cj. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):667-71. doi: 10.1016/j.ijrobp.2005.03.037. Epub 2005 May 31. Int J Radiat Oncol Biol Phys. 2005. PMID: 15927409 Clinical Trial.
369 results